Author | George W. Sledge Jr, MD | OncLive

Author | George W. Sledge Jr, MD

Articles

Looking for a Therapeutic Edge Among CDK Inhibitors

March 13, 2018

Article

Whenever 3 agents joining the therapeutic armamentarium do so for similar indications with essentially identical mechanisms of action, it is reasonable to ask whether these agents have specific differences that might help decide which to use.

Dr. Sledge on Impact of CDK 4/6 Agents in Breast Cancer

January 19, 2017

Video

George W. Sledge Jr., MD, professor of Medicine, Chief of the Division of Oncology, Stanford University Medical Center, discusses the use of cyclin-dependent kinase (CDK) 4/6 agents in the treatment of patients with breast cancer.

Dr. Sledge on Using PCR To Determine Therapy Benefit for Breast Cancer

March 24, 2015

Video

George W. Sledge, Jr., MD, professor of medicine, Stanford University School of Medicine discusses the benefits of using pathological complete response rate (PCR) to understand therapy benefit in breast cancer.

Dr. Sledge on Using Tumor Heterogeneity to Guide Treatment in Breast Cancer

February 28, 2015

Video

George W. Sledge, Jr., MD, professor of medicine, Stanford University School of Medicine, explains how tumor heterogeneity impacts patient care and research.

x